NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday

Published 26/06/2024, 13:12
© Reuters.  NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
NVDA
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Citigroup raised the price target for NVIDIA Corporation (NASDAQ:NVDA) from $126 to $150. Citigroup analyst Atif Malik maintained a Buy rating. NVIDIA shares gained 6.8% to close at $126.09 on Tuesday. See how other analysts view this stock.
  • Truist Securities raised the price target for Rivian Automotive, Inc. (NASDAQ:RIVN) from $10 to $13. Truist Securities analyst Jordan Levy maintained a Hold rating. Rivian Automotive shares gained 8.6% to close at $11.96 on Tuesday. See how other analysts view this stock.
  • BTIG cut Exact Sciences Corporation (NASDAQ:EXAS) price target from $80 to $70. BTIG analyst Mark Massaro maintained a Buy rating. Exact Sciences shares fell 1.4% to close at $41.37 on Tuesday. See how other analysts view this stock.
  • Morgan Stanley boosted the price target for FedEx Corporation (NYSE:FDX) from $210 to $215. Morgan Stanley analyst Ravi Shanker maintained an Equal-Weight rating. FedEx shares fell 0.1% to close at $256.38 on Tuesday. See how other analysts view this stock.
  • Goldman Sachs cut StoneCo Ltd. (NASDAQ:STNE) price target from $21 to $15. Goldman Sachs analyst Tito Labarta maintained a Buy rating. StoneCo shares gained 1.1% to close at $11.94 on Tuesday. See how other analysts view this stock.
  • B of A Securities raised Amazon.com, Inc. (NASDAQ:AMZN) price target from $210 to $220. B of A Securities analyst Justin Post maintained a Buy rating. Amazon shares gained 0.4% to close at $186.34 on Tuesday. See how other analysts view this stock.
  • HC Wainwright & Co. raised the price target for ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) from $87 to $94. HC Wainwright & Co. analyst Oren Livnat maintained a Buy rating. ANI Pharmaceuticals shares gained 2.2% to close at $64.19 on Tuesday. See how other analysts view this stock.
  • Deutsche Bank cut Repligen Corporation (NASDAQ:RGEN) price target from $180 to $155. Deutsche Bank analyst Justin Bowers upgraded the stock from Hold to Buy. Repligen shares fell 0.4% to close at $123.15 on Tuesday. See how other analysts view this stock.
  • BMO Capital raised United States Steel Corporation (NYSE:X) price target from $43 to $45. BMO Capital analyst Katja Jancic upgraded the stock from Market Perform to Outperform. United States Steel shares fell 2.9% to close at $35.21 on Tuesday. See how other analysts view this stock.
  • Morgan Stanley slashed Accenture plc (NYSE:ACN) price target from $382 to $300. Morgan Stanley analyst James Faucette downgraded the stock from Overweight to Equal-Weight. Accenture shares slipped 0.01% to close at $307.17 on Tuesday. See how other analysts view this stock.
Check This Out: FedEx, Micron And 3 Stocks To Watch Heading Into Wednesday

Latest Ratings for NVDA

DateFirmActionFromTo
Mar 2022Goldman SachsReinstatesNeutral
Feb 2022Summit Insights GroupDowngradesBuyHold
Feb 2022MizuhoMaintainsBuy
View More Analyst Ratings for NVDA

View the Latest Analyst Ratings

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.